CoreWeave Stock Sees Renewed Wall Street Interest Amid LongTerm AI Demand Outlook US Oil Prices Slide 6 Below 90 as Report Suggests Potential Iran Deal to Restore Hormuz Traffic Semiconductor Titans Hit 1 Trillion Samsung Ends Strike Micron Surges on AI Valuation Pentagons Wall Street Push Sparks Democratic Criticism Report Retail Chain to Close All Stores After 33 Years of Operations Richard Childress Racing Retires No 8 as Charlotte Motor Speedway Becomes a Memorial for Kyle Busch LAMR Q1 2026 Earnings EPS Beat Highlights Strong Profitability PDEX Q1 2026 Earnings Strong EPS Beat Drives Positive Stock Reaction Shoulder Innovations Inc SI Q1 2026 Earnings Narrower Loss Beats Estimates Despite Revenue Uncertainty Universal Display Q1 2026 Earnings EPS Misses Estimates Stock Gains MWA Q1 2026 Earnings Earnings Beat Estimates as EPS Surpasses Expectations TSSI Q1 2026 Earnings Massive EPS Beat Fails to Lift Stock as Revenue Remains Undisclosed Palladyne AI PDYN Moves Higher Gains 319 in Latest Session Invesco Quality Municipal Income Trust IQI Edges Higher as Bond Market Sentiment Improves VAALCO Energy EGY Slips 159 as Shares Test Key Support Near 542 American Eagle Outfitters AEO Bounces 36 as Retail Sector Finds Footing Haoxin Holdings HXHX Declines 207 Testing Support as Price Hovers Near 049 Robotic Automation Could Reshape Global Garment Manufacturing PAC Q1 2026 Earnings EPS Surges Past Estimates Stock Edges Lower Telesat Corporation TSAT Reaches 535 After a 257 Climb Key Levels in Focus Cable One Inc CABO Q1 2026 Earnings EPS Surpasses Estimates Amid Unreported Revenue Kairos Pharma Ltd KAPA Q1 2026 Earnings EPS Misses Estimates as PreRevenue Stage Continues CODX Q1 2026 Earnings Revenue Remains Elusive as EPS Misses Estimates Stock Surges 53 Scilex Holding SCLX Q1 2026 Earnings Reported EPS of 476 Stock Rises Over 6 Amid No Revenue EVTV Q4 2025 Earnings Significant Loss Per Share Reported as Company Navigates Challenges DT Q1 2026 Earnings EPS Surpasses Estimates by 237 Stock Declines Slightly OLMA Q1 2026 Earnings NarrowerthanExpected Loss as Clinical Progress Continues